Reference number : GC-2017-Q4-00361, amendment number : , agreement type : G, recipient legal name : Ciufolini, Marco (The University of British Columbia), recipient country : CA, recipient province : nan, recipient city : British Columbia|Colombie-Britannique, recipient postal code : nan, program name english : Engage Grants for universities, program name french : Subventions d'engagement partenarial pour les universités, program purpose english : ME Therapeutics, a Canadian pharmaceutical company located in Vancouver, BC, requires two anticancer_x000D_
compounds that are not available commercially and can only be produced by chemical synthesis. ME_x000D_
Therapeutics wishes to collaborate with the Applicant, a World-renowned synthetic organic chemist, to prepare_x000D_
the requisite materials., program purpose french : ME Therapeutics, a Canadian pharmaceutical company located in Vancouver, BC, requires two anticancer_x000D_
compounds that are not available commercially and can only be produced by chemical synthesis. ME_x000D_
Therapeutics wishes to collaborate with the Applicant, a World-renowned synthetic organic chemist, to prepare_x000D_
the requisite materials., agreement title english : Synthesis of a pharmaceutical product, agreement title french : Synthesis of a pharmaceutical product, agreement number : EGP, agreement value : 25000.0, agreement start date : 2018-03-07, agreement end date : nan, description english : nan, description french : nan, expected results english : nan, expected results french : nan, additional information english : Grant or Award spanning more than one fiscal year (2017-2018 to 2018-2019)., additional information french : Subvention ou bourse octroyée s'appliquant à plus d'un exercice financier (2017-2018 à 2018-2019)., owner organization : nserc-crsng, owner organization title : Natural Sciences and Engineering Research Council of Canada | Conseil de recherches en sciences naturelles et en génie du Canada